This pipeline uses various statistical tests to identify genes whose promoter methylation levels correlated to selected clinical features.
Testing the association between 17782 genes and 5 clinical features across 152 samples, statistically thresholded by Q value < 0.05, 4 clinical features related to at least one genes.
-
24 genes correlated to 'AGE'.
-
ALS2CL , SLFN14 , PIK3C2B , GPRC5C , NDOR1 , ...
-
971 genes correlated to 'HISTOLOGICAL.TYPE'.
-
WDTC1 , EXD1 , C7ORF70 , TMEM61 , CHP , ...
-
1 gene correlated to 'RADIATIONS.RADIATION.REGIMENINDICATION'.
-
TMEM125
-
1 gene correlated to 'NEOADJUVANT.THERAPY'.
-
ZFHX3
-
No genes correlated to 'Time to Death'
Complete statistical result table is provided in Supplement Table 1
Clinical feature | Statistical test | Significant genes | Associated with | Associated with | ||
---|---|---|---|---|---|---|
Time to Death | Cox regression test | N=0 | ||||
AGE | Spearman correlation test | N=24 | older | N=4 | younger | N=20 |
HISTOLOGICAL TYPE | ANOVA test | N=971 | ||||
RADIATIONS RADIATION REGIMENINDICATION | t test | N=1 | yes | N=1 | no | N=0 |
NEOADJUVANT THERAPY | t test | N=1 | yes | N=0 | no | N=1 |
Time to Death | Duration (Months) | 0-173.6 (median=12.6) |
censored | N = 143 | |
death | N = 9 | |
Significant markers | N = 0 |
AGE | Mean (SD) | 63.38 (11) |
Significant markers | N = 24 | |
pos. correlated | 4 | |
neg. correlated | 20 |
SpearmanCorr | corrP | Q | |
---|---|---|---|
ALS2CL | -0.4666 | 1.366e-09 | 2.43e-05 |
SLFN14 | 0.4424 | 1.149e-08 | 0.000204 |
PIK3C2B | -0.4163 | 9.564e-08 | 0.0017 |
GPRC5C | -0.4152 | 1.046e-07 | 0.00186 |
NDOR1 | -0.403 | 2.642e-07 | 0.0047 |
ACAA2 | -0.3969 | 4.139e-07 | 0.00736 |
SCARNA17 | -0.3969 | 4.139e-07 | 0.00736 |
PLA2G15 | -0.3956 | 4.552e-07 | 0.00809 |
NCRNA00203 | -0.3944 | 4.963e-07 | 0.00882 |
TAC3 | 0.392 | 5.907e-07 | 0.0105 |
HISTOLOGICAL.TYPE | Labels | N |
ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | 120 | |
ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1) | 1 | |
ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3) | 1 | |
MIXED SEROUS AND ENDOMETRIOID | 6 | |
SEROUS ENDOMETRIAL ADENOCARCINOMA | 24 | |
Significant markers | N = 971 |
ANOVA_P | Q | |
---|---|---|
WDTC1 | 6.534e-104 | 1.16e-99 |
EXD1 | 4.98e-83 | 8.86e-79 |
C7ORF70 | 6.68e-70 | 1.19e-65 |
TMEM61 | 5.283e-65 | 9.39e-61 |
CHP | 8.728e-56 | 1.55e-51 |
PNPO | 2.764e-50 | 4.91e-46 |
C9ORF80 | 4.563e-48 | 8.11e-44 |
ASCC3 | 9.97e-48 | 1.77e-43 |
LOC221442 | 1.327e-47 | 2.36e-43 |
GBP2 | 4.827e-42 | 8.58e-38 |
One gene related to 'RADIATIONS.RADIATION.REGIMENINDICATION'.
RADIATIONS.RADIATION.REGIMENINDICATION | Labels | N |
NO | 46 | |
YES | 106 | |
Significant markers | N = 1 | |
Higher in YES | 1 | |
Higher in NO | 0 |
T(pos if higher in 'YES') | ttestP | Q | AUC | |
---|---|---|---|---|
TMEM125 | 5.11 | 9.798e-07 | 0.0174 | 0.7334 |
NEOADJUVANT.THERAPY | Labels | N |
NO | 48 | |
YES | 104 | |
Significant markers | N = 1 | |
Higher in YES | 0 | |
Higher in NO | 1 |
T(pos if higher in 'YES') | ttestP | Q | AUC | |
---|---|---|---|---|
ZFHX3 | -4.92 | 2.504e-06 | 0.0445 | 0.6983 |
-
Expresson data file = UCEC.meth.for_correlation.filtered_data.txt
-
Clinical data file = UCEC.clin.merged.picked.txt
-
Number of patients = 152
-
Number of genes = 17782
-
Number of clinical features = 5
For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.